ACCC 40th National Oncology Conference Pre-Session: Clinical Updates from Chicago – A Focus on What Community Centers Need to Know to Move Their Solid Tumors' Practices Forward
Register Now!
20th Annual Meeting of the International Society of Gastrointestinal Oncology®
Register Now!
5th Annual Precision Medicine Symposium: An Illustrated Tumor Board
Register Now!
41st Annual CFS®: Innovative Cancer Therapy for Tomorrow®
Register Now!
PVd Confers a Small OS Benefit to Patients With Relapsed/Refractory Multiple Myeloma
Neoadjuvant Durvalumab Combination Misses Mark in EGFR+ NSCLC
Durvalumab Garners Similar OS, Albeit Varied PFS, Outcomes in EGFR+ and EGFR-Wildtype NSCLC Subgroups
Quizartinib Extends Overall Survival Across Multiple Subgroups in FLT3-ITD+ AML
2 Clarke Drive
Cranbury, NJ 08512